Ostiio Overview
- Year Founded
-
2017
- Status
-
Private
- Employees
-
3
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$3M
- Investors
-
9
Ostiio General Information
Description
Developer of a bone distraction system designed to correct skeletal deformities and deficiencies. The company's implant is fully buried under the patient's skin, eliminating the need for an external component, and the implant driver is programmable, allowing physicians to follow along with distraction progress remotely, enabling prescribing surgeons with proper transparency into, and control over, a process that has long been opaque.
Contact Information
Website
ostiio.comCorporate Office
- 3401 Grays Ferry Avenue
- Building 176-1011
- Philadelphia, PA 19146
- United States
Corporate Office
- 3401 Grays Ferry Avenue
- Building 176-1011
- Philadelphia, PA 19146
- United States
Ostiio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Grant | 14-Sep-2023 | $3M | Completed | Generating Revenue | ||
| 8. Later Stage VC (Series A) | 01-Aug-2022 | Completed | Generating Revenue | |||
| 7. Grant | 01-Jan-2022 | Completed | Generating Revenue | |||
| 6. Grant | 01-Dec-2021 | Completed | Generating Revenue | |||
| 5. Grant | 15-Jun-2021 | Completed | Generating Revenue | |||
| 4. Accelerator/Incubator | 01-Jan-2021 | Completed | Generating Revenue | |||
| 3. Seed Round | 01-Sep-2019 | Completed | Generating Revenue | |||
| 2. Accelerator/Incubator | 01-Jan-2017 | $500K | $500K | Completed | Generating Revenue | |
| 1. University Spin-Out | 01-Jan-2017 | Completed | Generating Revenue |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Ostiio Patents
Ostiio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4460248-A1 | Systems and processes for distraction control | Pending | 04-Jan-2022 | ||
| EP-4460248-A4 | Systems and processes for distraction control | Pending | 04-Jan-2022 | ||
| US-12551250-B2 | Systems and processes for distraction control | Active | 04-Jan-2022 | ||
| US-20230210566-A1 | Systems and processes for distraction control | Active | 04-Jan-2022 | ||
| US-20260137431-A1 | Systems and processes for distraction control | Pending | 04-Jan-2022 | A61B17/8004 |
Ostiio Signals
Ostiio Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| National Institutes of Health | Government | |||
| Ben Franklin Technology Partners of Southeastern Pennsylvania | Accelerator/Incubator | Minority | ||
| Lontra Ventures | Venture Capital | Minority | ||
| MassChallenge | Accelerator/Incubator | |||
| PennHealthX | Accelerator/Incubator |
Ostiio FAQs
-
When was Ostiio founded?
Ostiio was founded in 2017.
-
Where is Ostiio headquartered?
Ostiio is headquartered in Philadelphia, PA.
-
What is the size of Ostiio?
Ostiio has 3 total employees.
-
What industry is Ostiio in?
Ostiio’s primary industry is Therapeutic Devices.
-
Is Ostiio a private or public company?
Ostiio is a Private company.
-
What is Ostiio’s current revenue?
The current revenue for Ostiio is .
-
How much funding has Ostiio raised over time?
Ostiio has raised $1.02M.
-
Who are Ostiio’s investors?
National Institutes of Health, Ben Franklin Technology Partners of Southeastern Pennsylvania, Lontra Ventures, MassChallenge, and PennHealthX are 5 of 9 investors who have invested in Ostiio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process